Transfusion Flashcards

1
Q

Organism - RBC antigen associations

A

Big I = Mycoplasma pneumonia
Little i = EBV
H and Lewis B = H. pylori
P = Parvovirus B19
Duffy = P. vivax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Life span of blood products
pRBCs
FFP
Platelets
Cryoprecipitate

A

pRBCs - 35 days with CPDA-1, 42 days with Additive Solution

FFP - 1 year at -18C, 7 yearss at -65C with FDA approval, 24 hours after thaw

Platelets - 5-7 days at RT

Cryo - 1 year frozen, 4 hours after thaw

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antibodies in hemolytic disease of newborn

A

anti-AB
anti-D
anti-K
anti-Fya
anti-C
anti-c
anti-S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Components of cryoprecipitate

A

Fibrinogen
vWF
Factor 8
Factor 13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Partial D vs weak D vs Rh null

A

Partial D - altered antigen, may type as D+ but need D- blood

Weak D - decreased levels, may type as D- on immediate spin but IAT D+, can receive D+ blood

Rh null - chronic hemolytic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Blood type A2 typing

A

Forward type - A+

Reverse type - anti-A and anti-B (since make anti-A1 that react with commercial cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acquired B typing

A

Forward type- strong A+, weak B+
(B antigen acquired from bacteria deacetylating A antigen)

Reverse type - anti-B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RhIG - one vial covers how much D+ blood?

A

One vial RhIG = 30 mL blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

RhIG - Kleihauer-Betke equation

A

-Get % fetal (microscopy)
-Assume 5L maternal blood
-Fetal volume = % fetal x maternal volume
- Divide fetal volume by 30 mL
If decimal .0 to .4 - add 1 vial
If decimal .5 to .9 - add 2 vials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bombay vs Para-Bombay phenotype

A

Bombay: se/se h/h
No H antigens in blood or secretions

Para-Bombay: Se/se or Se/Se h/h
H antigens insecretions only

**Both need anti-H (Bombay) blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antigens enhanced by enzyme treatment

A

Enhanced - “A Rotten Kid LIP”
ABO
Rh
Kidd
Lewis
I
P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antigens decreased by enzyme treatment

A

Decreased - “My Dog Lassie”
MNS
Duffy
Lutheran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lewis A vs Lewis B genetics

A

Le gene makes Lewis A
Se gene makes H (H + LeA = LeB)

Le Le/le + Se Se/se = Lewis A+ Lewis B+ secretions and Lewis B+ RBCs

Le Le/le + se se = Lewis A+ LewisB- secretions and RBCs

le le + Se Se/se = Lewis A- Lewis B - secretions and RBCs (but still H+ secrtions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lewis antibodies - type, significance

A

anti-Lewis
IgM, clinically insignificant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

I/i antibodies - significanc

A

anti-I/i
Clinically insignificant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rh antigen nomenclature
R1
R2
R0
Rz

A

R = D+
R1 = DCe
R2 = DcE
R0 = Dce
Dz = DCE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Rh antigen nomenclature
r
r’
r’’
rgamma

A

r = D-
r = ce
r’ = Ce
r’’ = cE
rgamma = CE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MNS antibodies - exposure, type, significance

A

anti-M/N - natural, IgM, rare significance

anti-S - exposure, IgG, significant

19
Q

Kell antibodies - significance

A

anti-K and anti-k - both very significant

20
Q

McLeod Syndrome

A

McLeod syndrome
X-linked, absence of Kell antigens
Acantholytic hemolytic anemia and late onset neuromuscular

21
Q

Duffy antibodies - type, significance

A

anti-Duffy
IgG, significant

22
Q

Permanent donation deferrals

A

Dura mater graft
Bovine insulin, HGH or CJD
HBV, HCV, HIV, HTLV
Etretinate
Antiretroviral treatment

23
Q

3 year donation deferrals

A

History of malaria, residence in malaria country > 5 y

24
Q

1 year donation deferrals

A

Incarceration > 72 h
Sex with HBV

25
Q

3 mo donation deferrals

A

Needle stick
HIV risks (MSM, money)
Hx transfusion
Travel to malaria
Syphilis or gonorrhea

26
Q

Vaccine donation deferrals:
No deferral
2 week referral
4 week deferral

A

Vaccine deferrals:
- No deferral - toxoids, killed or recombinant vaccines
- 2 week - live attenutated, measles, mumps, polio, typhoid, yellow fever
- 4 week - Rubella, Chicklpox / shingles, unlicensed vaccines

27
Q

Donation Physical Criteria
Weight
Temp
Pulse
BP
Hgb/Hct

A

Donation Criteria:
Weight - > 50 kg
Temp - < 99.5 F
Pulse - 50-100 bpm
Bp - 90-180 / 50-100
Hgb/hct- Females 12.5/38%, Males 13.0/39%

28
Q

Expected change in Hgb from 1u pRBCs

A

1 g/dL Hgb (3% Hct)

29
Q

Apheresis platelets - adv vs disadv

A

Apheresis platelets
Adv
- fewer allergic rxns
- less hemolysis from plasma
- single donor so can HLA match

Disadv - lower increment

30
Q

Leukoreduction benefits

A

Leukoreduction:
- Decreased febrile reactions
- Decreased CMV transmission
- Decreased HLA immunization

31
Q

Irradiation benefits

A

Irradiation:
- GVHD

32
Q

RBC Washing Benefits

A

Washed RBCs (remove plasma and Igs):
- Large volume to K sensitive patients, esp neonates when fresh units not avail
- History of plasma-related reactions (eg IgA defic or anaphylactic rxns)

33
Q

Indications for plasma transfusion

A

Plasma indications:

Bleeding with multiple factor defic:
- Liver disease
- DIC
- Dilutional coagulopathy

Congenital factor defic with no concentrates - 5 and 11

Life threatening anti-coagulation reversal

34
Q

RBC lifespan after irradiatio

A

Original date or 28 days after irradiation

35
Q

Acute hemolytic reaction
Sx
Labs
Tx

A

Acute hemolytic reaction
- Sx: fever, pain. Severe: hypotension, dyspnea
- Labs: positive DAT, indirect hyperbiliubinema, schistocytes or spherocytes
- Tx: volume and BP support, maintain urine

36
Q

Transfusion related sepsis
Sx
Dx
Prevention

A

Transfusion related sepsis
- Sx: fever > 38C with > 1 C increase, rigors, hypotension
- Dx: Gram stain, culture matching patient
- Prevention: clean skin, divert first 10-40 mL to container

37
Q

Febrile non hemolytic reaction
Sx
Dx
Timing
Tx

A

FNHTR
- Sx: shaking, increase RR, change in BP
- Dx: >38C with > 1 C increase.
- Timing: within 4 hours
- Tx: stop transfusion, check no hemolysis

38
Q

Allergic Transfusion Reaction
Sx
Timing
Tx
Prevention

A

Allergic Transfusion Reaction
- Sx: urticaria
- Timing: within 4 hours
- Tx: pause transfusion, give antihstamine, resume once resolves
- Prevention: wash products

39
Q

TACO
Sx
Dx
Tx
Prevention

A

TACO
- Sx: tachycardia, hypertension, dyspnea

-Dx:
Three of more of:
- One of - A) acute or worsening resp compromise, B) Evidence of worsening pulmonary edema (clinical or radiographic)
- CV changes (tachy, BP, EKG)
- Fluid overload (resp to diuretics, weight)
- Releveant biomarker (BNP)

  • Tx: stop tfn, O2. diuretics
  • Prevention: transfuse at risk patients slowly (2-4 mL/min or 1 mL/kg per hour)
40
Q

Delayed hemolytic reaction
Sx
Labs

A

DHTR
- Sx: often none but can be fever, anemia, jaundice
- Labs: increased LDH, bilirubin, DAT+, newly positive screen, spherocytes

41
Q

Transfusion associated GVHD
Sx
Prevention

A

Transfusion associated GVHD
- Sx: erythroderma, vomiting, diarrhea, hepatitis, pancytiopenia
- Prevention: irradiation at risk patients ( tfn from blood relatives or HLA compatible)

42
Q

Indications for irradiation of products

A

Indications for irradiation:
- Intrauterine transfusions
- Prematurity, low birthweight
- Congenital immunodef
- Heme malignancy
- Stem cell transplant
- Crosmatched or family donation
- Fludarabine therapy

43
Q

Typical cold RBC antibodies

A

Le a
Le b
M
N
P